About
CereVu develops a wearable sensor platform using AI-derived biomarkers and near-infrared spectroscopy to objectively and continuously measure pain and dyspnea for clinical research.
Explore CereVu's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.